ZNF530 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.603600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.290600E-01
Normal-vs-Stage2
3.583800E-01
Normal-vs-Stage3
1.618040E-01
Normal-vs-Stage4
4.958800E-01
Stage1-vs-Stage2
8.547200E-01
Stage1-vs-Stage3
4.941800E-01
Stage1-vs-Stage4
5.018800E-01
Stage2-vs-Stage3
4.748200E-01
Stage2-vs-Stage4
2.809600E-01
Stage3-vs-Stage4
1.889400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.773000E-01
Normal-vs-AfricanAmerican
2.610800E-01
Normal-vs-Asian
4.684000E-02
Caucasian-vs-AfricanAmerican
1.883180E-01
Caucasian-vs-Asian
1.148790E-01
AfricanAmerican-vs-Asian
9.189200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.392600E-01
Normal-vs-Female
4.918300E-02
Male-vs-Female
1.946430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.156800E-01
Normal-vs-Age(41-60Yrs)
4.231000E-01
Normal-vs-Age(61-80Yrs)
3.425000E-01
Normal-vs-Age(81-100Yrs)
4.407900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.326600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.978800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.871200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.525700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.217450E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.422000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.001800E-01
Normal-vs-Daily Drinker
3.414000E-01
Normal-vs-Weekly Drinker
1.707630E-01
Normal-vs-Occasional Drinker
3.904400E-01
Normal-vs-Social Drinker
4.274600E-01
Non Drinker-vs-Daily Drinker
5.011600E-01
Non Drinker-vs-Weekly Drinker
6.894000E-01
Non Drinker-vs-Occasional Drinker
1.695030E-01
Non Drinker-vs-Social Drinker
7.783700E-02
Daily Drinker-vs-Weekly Drinker
9.883600E-01
Daily Drinker-vs-Occasional Drinker
4.742600E-01
Daily Drinker-vs-Social Drinker
2.433000E-01
Weekly Drinker-vs-Occasional Drinker
6.938200E-01
Weekly Drinker-vs-Social Drinker
5.036200E-01
Occasional Drinker-vs-Social Drinker
5.935000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.530200E-01
Normal-vs-Grade 2
7.448200E-01
Normal-vs-Grade 3
7.681800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.595000E-01
Grade 1-vs-Grade 3
7.391200E-01
Grade 1-vs-Grade 4
7.530200E-01
Grade 2-vs-Grade 3
3.365200E-01
Grade 2-vs-Grade 4
7.448200E-01
Grade 3-vs-Grade 4
7.681800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.125600E-01
Normal-vs-NonDiabetic
3.710600E-01
Diabetic-vs-NonDiabetic
1.975760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.638600E-01
Normal-vs-NoPancreatitis
3.617400E-01
Pancreatitis-vs-NoPancreatitis
1.090570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.585000E-01
Normal-vs-N1
3.582800E-01
N0-vs-N1
9.851600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.897400E-01
Normal-vs-TP53-NonMutant
4.375400E-01
TP53-Mutant-vs-TP53-NonMutant
4.420400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
